Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors
Cardiac hypertrophy is a key process in cardiac remodeling development, leading to ventricle enlargement and heart failure. Recently, studies show the complicated relation between cardiac hypertrophy and epigenetic modification. Post-translational modification of histone is an essential part of epig...
Main Authors: | Yu Han, Jiali Nie, Dao Wen Wang, Li Ni |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2022.931475/full |
Similar Items
-
Histone Deacetylases and their Inhibitors in Cancer Epigenetics
by: Kelly N. Hassell
Published: (2019-11-01) -
Potential of histone deacetylase inhibitors for the therapy of ovarian cancer
by: Fengyi Guo, et al.
Published: (2022-11-01) -
Histone Deacetylases and Their Isoform-Specific Inhibitors in Ischemic Stroke
by: Svetlana Demyanenko, et al.
Published: (2021-10-01) -
Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
by: Monica Phimmachanh, et al.
Published: (2020-10-01) -
Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
by: Masumeh Sanaei, et al.
Published: (2019-01-01)